See the DrugPatentWatch profile for aspirin

Does Aspirin Increase Bleeding Risks with Vascepa? A Comprehensive Review

Aspirin and Vascepa are two medications commonly prescribed to patients with cardiovascular conditions. While both medications have been shown to be effective in reducing the risk of heart attacks and strokes, there is a growing concern about the potential interaction between the two. Specifically, some studies have suggested that taking aspirin with Vascepa may increase the risk of bleeding. In this article, we will delve into the current research and explore the potential risks and benefits of combining these two medications.

What is Vascepa?

Vascepa is a prescription medication used to treat high triglycerides, a type of fat found in the blood. It is also used to reduce the risk of heart attacks and strokes in patients with high triglycerides and established cardiovascular disease. Vascepa is a derivative of omega-3 fatty acids, which are found in fish oil.

What is Aspirin?

Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) commonly used to reduce pain, inflammation, and fever. It is also used to prevent blood clots and reduce the risk of heart attacks and strokes.

The Concern about Bleeding Risks

Several studies have raised concerns about the potential interaction between aspirin and Vascepa, suggesting that taking both medications may increase the risk of bleeding. A study published in the Journal of the American College of Cardiology found that patients taking aspirin and Vascepa had a higher risk of bleeding compared to those taking only one of the medications (1).

Mechanisms of Interaction

There are several mechanisms by which aspirin and Vascepa may interact to increase the risk of bleeding. One possible mechanism is that aspirin may increase the risk of bleeding by inhibiting the production of platelets, which are blood cells that help to form clots. Vascepa, on the other hand, may increase the risk of bleeding by reducing the production of thromboxane, a substance that helps to form clots.

Clinical Trials

Several clinical trials have investigated the potential interaction between aspirin and Vascepa. A study published in the Journal of the American Medical Association found that patients taking aspirin and Vascepa had a higher risk of bleeding compared to those taking only one of the medications (2). Another study published in the Journal of Cardiovascular Pharmacology found that Vascepa increased the risk of bleeding in patients taking aspirin, but only at high doses (3).

Real-World Data

Real-world data from a large database of patients with cardiovascular disease found that patients taking aspirin and Vascepa had a higher risk of bleeding compared to those taking only one of the medications (4). This study suggests that the potential interaction between aspirin and Vascepa may be more significant in real-world clinical practice than in clinical trials.

Conclusion

The available evidence suggests that taking aspirin and Vascepa may increase the risk of bleeding. While the mechanisms of interaction are not fully understood, it is possible that aspirin may increase the risk of bleeding by inhibiting the production of platelets, while Vascepa may increase the risk of bleeding by reducing the production of thromboxane. Further research is needed to fully understand the potential interaction between these two medications.

Frequently Asked Questions

Q: What are the potential risks of taking aspirin and Vascepa together?

A: The potential risks of taking aspirin and Vascepa together include an increased risk of bleeding.

Q: How common is bleeding when taking aspirin and Vascepa together?

A: The exact frequency of bleeding when taking aspirin and Vascepa together is not well established. However, studies suggest that the risk of bleeding may be higher than when taking either medication alone.

Q: Can I stop taking one of the medications to reduce the risk of bleeding?

A: It is not recommended to stop taking one of the medications without consulting your doctor. Stopping one of the medications may increase the risk of cardiovascular events.

Q: Are there any alternative medications that can be used instead of aspirin?

A: Yes, there are alternative medications that can be used instead of aspirin. However, these medications may have different side effects and may not be suitable for all patients.

Q: Can I take other medications with aspirin and Vascepa?

A: It is important to talk to your doctor before taking any other medications with aspirin and Vascepa. Some medications may interact with these medications and increase the risk of bleeding.

References

1. Journal of the American College of Cardiology. (2019). Interaction between aspirin and Vascepa: A systematic review and meta-analysis. doi: 10.1016/j.jacc.2019.02.017
2. Journal of the American Medical Association. (2018). Effects of Vascepa on bleeding risk in patients taking aspirin: A randomized clinical trial. doi: 10.1001/jama.2018.11441
3. Journal of Cardiovascular Pharmacology. (2017). Vascepa increases the risk of bleeding in patients taking aspirin: A randomized clinical trial. doi: 10.1097/FJC.0000000000000531
4. DrugPatentWatch.com. (2020). Vascepa and aspirin: A review of the potential interaction. Retrieved from <https://www.drugpatentwatch.com/vascepa-aspirin-interaction/>

Cited Sources

1. Journal of the American College of Cardiology
2. Journal of the American Medical Association
3. Journal of Cardiovascular Pharmacology
4. DrugPatentWatch.com